Literature DB >> 1409679

Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

D R Karp1, R N Jenkins, E O Long.   

Abstract

During biosynthesis, class II molecules of the major histocompatibility complex exist as complexes of the polymorphic alpha and beta chains in association with trimers of the invariant chain (Ii). The nonpolymorphic Ii contains sequences necessary for proper targeting of class II to endosomal compartments, where Ii is degraded. Ii also prevents the premature association of antigenic peptides with class II molecules. It is not known whether the effect of Ii on peptide binding extends to other ligands of class II, specifically exogenous superantigens. Cells expressing a mutant Ii molecule stably associated with HLA-DR at the cell surface were tested for their ability to interact with staphylococcal toxins. Most toxins (staphylococcal enterotoxins A-E and exfoliative toxin) were found to bind to cells expressing this alpha beta Ii complex with levels comparable to cells expressing only alpha beta chains at the cell surface. Cells expressing surface alpha beta Ii complexes stimulated polyclonal populations of peripheral blood T cells in association with these toxins. Binding of toxic shock syndrome toxin (TSST) and subsequent stimulation of T cells were reduced by the presence of the Ii. This reduction was not due to an alteration in the repertoire of T cells responding to TSST in the presence of Ii. Data from experiments with a T-cell clone suggest that interactions between class II molecules and T-cell antigen receptors occur during staphylococcal enterotoxin-mediated stimulation and that surface Ii does not interfere with such interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409679      PMCID: PMC50191          DOI: 10.1073/pnas.89.20.9657

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Invariant chain--a regulator of antigen presentation.

Authors:  L Teyton; P A Peterson
Journal:  Trends Cell Biol       Date:  1992-02       Impact factor: 20.808

2.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

Authors:  L J Stern; D C Wiley
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

3.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

Authors:  L Teyton; D O'Sullivan; P W Dickson; V Lotteau; A Sette; P Fink; P A Peterson
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

4.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 7.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.

Authors:  A Herman; N Labrecque; J Thibodeau; P Marrack; J W Kappler; R P Sekaly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.

Authors:  A Herman; G Croteau; R P Sekaly; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens.

Authors:  M S Marks; J S Blum; P Cresswell
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  8 in total

1.  Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

Authors:  A Jasanoff; G Wagner; D C Wiley
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

2.  Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.

Authors:  P M Lavoie; J Thibodeau; I Cloutier; R Busch; R P Sékaly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

3.  The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides.

Authors:  I M Freisewinkel; K Schenck; N Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.

Authors:  H Kropshofer; A B Vogt; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

5.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  T cell receptor V beta gene bias in rheumatoid arthritis.

Authors:  R N Jenkins; A Nikaein; A Zimmermann; K Meek; P E Lipsky
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

8.  Characterization and biological properties of a new staphylococcal exotoxin.

Authors:  K Ren; J D Bannan; V Pancholi; A L Cheung; J C Robbins; V A Fischetti; J B Zabriskie
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.